Source: Annual Congress 2012 - COPD exacerbation
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Baimakanova, S. Avdeev, A. Chuchalin (Moscow, Russian Federation). The prognostic value of elevated levels of troponin I (Tn I) and heart-type fatty acid binding protein (H-FABP) in hospitalized COPD patients with acute respiratory failure (ARF). Eur Respir J 2012; 40: Suppl. 56, 4812

Member's Comments

No comment yet.

Related content which might interest you: Relation of troponin and hert type fatty acid protein (H-FABP) levels to echocardiographic and cardiac infarction injury score (CIS) with patients with prespiratory insufficiency due to COPD attack Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 Heart-type fatty acid binding protein (H-FABP) and brain natriuretic peptide-fragment (BNP-fragment) in COPD patients with pneumonia Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Is a cardiopulmonary exercise test (CPET) associated with an increase in high sensitivity cardiac troponin T (hs-cTnT) levels in patients with COPD? Source: International Congress 2017 – Lung function practice in daily life Year: 2017 Procalcitonin (PCT) and C-reactive protein (CRP) as markers of the differential diagnosis of severe community acquired pneumonia (sCAP) Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 Prognostic value of high troponin levels in acute COPD attack patients with respiratory insufficiency Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 C-reactive protein (CRP) utility in severe community-acquired pneumonia (SCAP) prognosis Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 C-reactive protein (CRP) as a risk marker in COPD patients with ischaemic heart disease Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level Source: Annual Congress 2013 –COPD mechanisms Year: 2013 The discriminatory value of procalcitonin (PCT) and C-reactive protein (CRP) levels in HIV-seropositive patients presenting with community acquired pneumonia (CAP) due to pulmonary tuberculosis (PTB) compared with patients with pneumococcal pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 241s Year: 2004 Serum C-reactive protein (CRP) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP) Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007 C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 C-reactive protein (C-RP) in patients with chronic heart failure (CHF) and community-acquired pneumonia (CAP): usefulness to guide antibiotic prescription Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 Surfactant protein D (SPD) and C-reactive protein (CRP) in patient with low respiratory tract infections (LRTI) Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. Source: International Congress 2017 – COPD biomarkers Year: 2017 Usefulness of troponin-1, lactate and c-reactive protein as a prognostic markers in critically ill, non cardiac patients Source: Eur Respir J 2005; 26: Suppl. 49, 436s Year: 2005 C-reactive protein (CRP), an early prognostic tool in community acquired pneumonia (CAP) Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Changes in levels of inflammatory markers (procalcitonin, C-reactive protein) in pregnant with community-acquired pneumonia (CAP) Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 COPD: Acute exacerbation (AE) and hospitalization rate (HR) in patients with different serum surfactant protein D (SPD) level Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Diagnostic accuracy of lipopolysaccharide-binding protein (LBP), fibrinogen and C-reactive protein (CRP) in differentiating pneumonia from acute bronchitis in primary care Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care Year: 2008 Plasma surfactant protein D (SP-D) in patients (pts) with stable (S) COPD and during COPD acute exacerbation (AE) Source: Annual Congress 2013 –COPD biomarkers Year: 2013